A model-based study claims that 3 to 8 month gaps between vaccine doses are cost-optimal, but the result rests on unvalidated assumptions and an inconsistent susceptible-population equation.
The evolution of ebola virus: Insights from the 2013–2016 epidemic
1 Pith paper cite this work. Polarity classification is still indexing.
1
Pith paper citing it
citation-role summary
background 1
citation-polarity summary
fields
q-bio.PE 1years
2025 1verdicts
REJECT 1roles
background 1polarities
unclear 1representative citing papers
citing papers explorer
-
Effect of Vaccine Dose Intervals: Considering Immunity Levels, Vaccine Efficacy, and Strain Variants for Disease Control Strategy
A model-based study claims that 3 to 8 month gaps between vaccine doses are cost-optimal, but the result rests on unvalidated assumptions and an inconsistent susceptible-population equation.